ArticleAdvances in rheumatology (London, England)2026

Effects of SGLT2 inhibitors on gout-related and cardiometabolic outcomes in patients with type 2 diabetes mellitus: a scoping review.

Henrique Pereira Sampaio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.